Vertex Celebrates the 50th Science and Medicine Seminar
October 16, 2018
By David Altshuler
Executive Vice President, Global Research and Chief Scientific Officer
At Vertex, we have a nerdy side. Our passion for science, for relentless problem solving, and for helping other people propels us to discover and develop new medicines for patients with serious diseases. One way we feed our intellectual curiosity and challenge ourselves is by engaging with great scientists outside our walls. In 2016, we launched the Science and Medicine Seminar Series to connect Vertexians to cutting-edge science.
Last week we hosted Laura Kiessling from MIT for our 50th seminar.
Over the last two years, we’ve learned about human biology from Rick Lifton, Aviv Regev, Stuart Orkin, Kay Davies, Jeannie Lee, and Emery Brown; we’ve heard about advances in therapeutic science from Mark Bunnage, David Liu, Phil Baran, Tom Blundell, Laura Kiessling, and Sriram Subramaniam; and we’ve examined innovation ecosystems with Lita Nelsen, Vijay Pande, Anthony Philippakis and Atul Gawande. We’ve even peered inside our own thought processes with Mahzarin Banaji, Paul Zak, and Pat Connelly.
Whether digging deep on a topic relevant to our current work, or exploring a new ways of thinking, Science and Medicine speakers challenge us. They make us to step outside of our own work for an hour to learn something new, to meet and debate with Vertexians from across the company, and to get to know extraordinary scientists from across the broader community.
Fifty seminars later, we have learned that engaging new and diverse perspectives is fuel for our culture of serial innovation. A special thank you to all the speakers that we’ve welcomed in the last two years – and for those to come!